InnovAge Holding Corp. (INNV) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $137.00K; Additional Paid in CapitalUSD $348.72M; Treasury Stock, Common, ValueUSD $7.50M; Retained Earnings (Accumulated Deficit)USD $-105.76M.
- 2026-03-31: Common Stock, Value, IssuedUSD $137.00K; Additional Paid in CapitalUSD $348.26M; Treasury Stock, Common, ValueUSD $7.50M; Retained Earnings (Accumulated Deficit)USD $-111.87M.
- 2025-12-31: Common Stock, Value, IssuedUSD $137.00K; Additional Paid in CapitalUSD $346.56M; Treasury Stock, Common, ValueUSD $7.50M; Retained Earnings (Accumulated Deficit)USD $-82.41M.
- 2025-09-30: Common Stock, Value, IssuedUSD $137.00K; Additional Paid in CapitalUSD $345.37M; Treasury Stock, Common, ValueUSD $7.50M; Retained Earnings (Accumulated Deficit)USD $-93.03M.
InnovAge Holding Corp. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Treasury Stock, Value USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $137.00K | $348.72M | $7.50M | $-105.76M | $235.60M | $238.76M | 1.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $137.00K | $348.26M | $7.50M | $-111.87M | $229.03M | $232.78M | 1.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $137.00K | $346.56M | $7.50M | $-82.41M | $256.79M | $261.17M | 1.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $137.00K | $345.37M | $7.50M | $-93.03M | $244.98M | $249.83M | 1.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $137.00K | $343.38M | $7.50M | $-101.05M | $234.97M | $237.90M | 1.46M | 12 month · $7.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $136.00K | $342.87M | $7.20M | $-97.84M | $237.96M | $245.60M | 1.36M | 3 month · $1.11M 9 month · $7.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $136.00K | $340.87M | $6.09M | $-86.46M | $248.46M | $256.34M | 1.05M | 3 month · $1.09M 6 month · $5.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $136.00K | $339.05M | $5.00M | $-73.24M | $260.94M | $269.05M | 837.37K | 3 month · $4.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $136.00K | $337.62M | $179.00K | $-68.31M | $269.26M | $277.61M | 36.56K | 12 month · $179.00K | 12 month · $2.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $136.00K | $336.60M | (m) | $-55.58M | $281.15M | $286.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $136.00K | $335.06M | (m) | $-49.70M | $285.50M | $291.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $136.00K | $333.32M | (m) | $-46.25M | $287.20M | $292.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $136.00K | $332.11M | $0.00 | $-35.94M | $296.30M | $302.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $136.00K | $330.95M | (m) | $-24.77M | $306.32M | $312.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $136.00K | $329.78M | (m) | $-18.14M | $311.78M | $317.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $136.00K | $328.71M | (m) | $-8.34M | $320.50M | $326.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $136.00K | $327.50M | (m) | $4.73M | $332.36M | $338.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $136.00K | $326.35M | (m) | $17.44M | $343.92M | $350.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $136.00K | $325.50M | (m) | $17.70M | $343.33M | $349.59M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $783.00K 6 month · $1.74M | (m) | (m) | (m) |
| 2021-09-30 | $136.00K | $324.72M | (m) | $18.94M | $343.79M | $350.12M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $958.00K | (m) | (m) | (m) |
| 2021-06-30 | $136.00K | $323.76M | (m) | $10.66M | $334.56M | $340.98M | 0.00 | 12 month · $77.60M | (m) | (m) | 12 month · $28.45M | (m) | 12 month · $1.66M | 12 month · 0.00 | 12 month · 0.00 | 0.00 |
| 2021-03-31 | $136.00K | $323.13M | (m) | $4.82M | $328.08M | $334.14M | 0.00 | 9 month · $77.60M | (m) | (m) | 3 month · $25.33M 9 month · $25.33M | (m) | 3 month · $530.00K 9 month · $1.10M | (m) | 9 month · 0.00 | 0.00 |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $-31.29M | (m) | 6 month · $77.60M | (m) | (m) | (m) | (m) | 3 month · $526.00K 6 month · $572.00K | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-61.42M | (m) | 3 month · $77.60M | (m) | (m) | (m) | (m) | 3 month · $46.00K | (m) | (m) | (m) |
| 2020-07-27 | (m) | (m) | $77.60M | (m) | (m) | (m) | 16.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.82 | (m) |
| 2020-06-30 | $133.00K | $36.34M | (m) | $64.74M | $101.02M | $107.75M | (m) | (m) | (m) | $193.00K | (m) | 12 month · $543.00K | (m) | (m) | 12 month · 1.89 | 102.03K |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $95.64M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $135.00K 9 month · $407.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $87.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $81.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |